In Financial Times, Dannell Boatman, a professor who has studied online discourse about mRNA, says despite breakthroughs in mRNA technology for cancer vaccines, skepticism, misinformation, and political tension could stunt its acceptance.
“Moderna’s melanoma results were likely to ‘amplify’ political divisions over mRNA,” Boatman said.
“We’ve seen a lot of mistrust and distrust for vaccines in general,” she said. “We’ve had this burst of misinformation since the pandemic surrounding mRNA technology, and that is not going away.”
To request the full article, send an email to WVUToday@mail.wvu.edu.